Latest Breaking News On - Corporate communications abeona therapeutics - Page 1 : comparemela.com

Abeona Therapeutics Reports Second Quarter 2023 Financial Results

On track for Biologics License Application (BLA) submission in third quarter of 2023

Exchange commissionSociety for pediatric dermatologySecurities exchangeAbeona therapeutics incCorporate communications abeona therapeuticsDrug administrationInternational societies for investigative dermatologyBiologics license applicationVish seshadriChief executive officerProcess performance qualificationInternational societiesInvestigative dermatologyPediatric dermatologyInvestigational new drug applicationAnnual meeting

Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update

Expects to submit BLA for EB-101 to FDA in late-2Q/early-3Q 2023 based on positive Phase 3 VIITAL™ study results announced in 4Q 2022 Advancing AAV-based gene therapy. | March 29, 2023

Dmitriy grachevAmanda mooreJoe vazzanoMadhav vasanthavadaAbeona therapeutics incHead of program leadershipCorporate communications abeona therapeuticsExchange commissionBristol myers squibbProgram leadershipInternational societies for investigative dermatologyBusiness developmentSecurities exchangeDrug administrationStargardt diseaseX linked retinoschisis

Abeona Therapeutics Announces New Employee Inducement Grants

Abeona Therapeutics Announces New Employee Inducement Grants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Corporate communications abeona therapeuticsAbeona therapeutics incCompensation committeeNasdaq ruleAbeona therapeuticsMedia contactGreg ginInvestor relations

Abeona Therapeutics Reports Third Quarter 2022 Financial Results

Abeona Therapeutics Reports Third Quarter 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionCorporate communications abeona therapeuticsAbeona therapeutics incSecurities exchangeDrug administrationVish seshadriChief executive officerBiologics license applicationRecent operatingPriority review voucherOrphanet journalInvestigational new drug applicationAbeona therapeuticsLooking statementsthisSecurities actSecurities exchange act

Abeona Therapeutics to Participate in the Cantor Fitzgerald Cell and Genetic Medicines Conference

Abeona Therapeutics to Participate in the Cantor Fitzgerald Cell and Genetic Medicines Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Corporate communications abeona therapeuticsCantor fitzgeraldAbeona therapeutics incWall streetVish seshadriChief executive officerCantor fitzgerald cellGenetic medicines conferenceCommercial geneCell therapy warriorsHow they gotFinish lineAbeona therapeuticsMedia contactGreg ginInvestor relations